Schneiter P, Gillet M, Chioléro R, Jéquier E, Mosimann F, Temler E, Téta D, Matter M, Wauters J P, Tappy L
Institute of Physiology, University of Lausanne, Switzerland.
Diabetes Metab. 2000 Feb;26(1):51-6.
Impaired glucose tolerance or diabetes mellitus are frequent complications after organ transplantation, and are usually attributed to glucocorticoid and immunosuppressive treatments. Liver transplantation results in total hepatic denervation which may also affect glucoregulation. We therefore evaluated postprandial glucose metabolism in a group of patients with liver cirrhosis before and after orthotopic liver transplantation. Seven patients with liver cirrhosis of various etiologies, 6 patients having received a kidney transplant, and 6 healthy subjects were studied. Their glucose metabolism was evaluated in the basal state and over 4 hours after ingestion of a glucose load with 6.6 (2) H glucose dilution analysis. The patients with liver cirrhosis were studied before, and again 4 weeks (range 2-6) and 38 weeks (range 20-76, n=6) after orthotopic liver transplantation. Basal glucose metabolism was similar in liver and kidney transplant recipients. Impaired glucose tolerance was present in both groups, but postprandial hyperglycemia was exaggerated and lasted longer in liver transplant patients. Postprandial insulinemia was lower in liver transplant recipients, while C-peptide concentrations were comparable to those of kidney transplant recipients, indicating increased insulin clearance. Glucose turnover was not altered in both groups of patients during the initial 3 hours after glucose ingestion, but was higher in liver transplant early after transplantation during the fourth hour. Postprandial hyperglycemia remained unchanged in liver transplant recipients 38 weeks after liver transplantation, despite substantial reduction of immunosuppressive and glucocorticoid doses. We conclude that liver transplant recipients have severe postprandial hyperglycemia which can be attributed to insulinopenia (secondary, at least in part, to increased insulin clearance) and a late increased glucose turnover. These changes may be secondary to hepatic denervation.
糖耐量受损或糖尿病是器官移植后常见的并发症,通常归因于糖皮质激素和免疫抑制治疗。肝移植导致肝脏完全去神经支配,这也可能影响葡萄糖调节。因此,我们评估了一组肝硬化患者原位肝移植前后的餐后葡萄糖代谢情况。研究了7例不同病因的肝硬化患者、6例接受肾移植的患者和6名健康受试者。通过6.6(2)H葡萄糖稀释分析,在基础状态以及摄入葡萄糖负荷后4小时内评估他们的葡萄糖代谢。对肝硬化患者在原位肝移植前、移植后4周(范围2 - 6周)和38周(范围20 - 76周,n = 6)进行研究。肝移植受者和肾移植受者的基础葡萄糖代谢相似。两组均存在糖耐量受损,但肝移植患者的餐后高血糖更为严重且持续时间更长。肝移植受者的餐后胰岛素血症较低,而C肽浓度与肾移植受者相当,表明胰岛素清除增加。两组患者在摄入葡萄糖后的最初3小时内葡萄糖周转率未改变,但肝移植患者在移植后的第四小时早期葡萄糖周转率较高。尽管免疫抑制和糖皮质激素剂量大幅减少,但肝移植受者在肝移植38周后餐后高血糖仍未改变。我们得出结论,肝移植受者存在严重的餐后高血糖,这可归因于胰岛素缺乏(至少部分是继发性的,由于胰岛素清除增加)和后期葡萄糖周转率增加。这些变化可能继发于肝脏去神经支配。